MABPREX, INC. is a privately-held biotechnology company founded in 2009 and headquartered in San Diego, California. MabPrex develops novel monoclonal antibodies and biobetters as well as other protein therapeutics. In addition, we develop and optimize upstream and downstream processes for antibody therapeutics. The MabPrex team is composed of a group of highly experienced professionals with a broad range of expertise that complements each other.